Leukemia Clinical Trials in Reggio Emilia
7 recruitingReggio Emilia, Italy
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
CLLLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Small Lymphocytic+3 more
Merck Sharp & Dohme LLC735 enrolled52 locationsNCT05947851
Recruiting
Phase 3
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLeukemia, B-cell+1 more
Loxo Oncology, Inc.662 enrolled144 locationsNCT05254743
Recruiting
Not Applicable
The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease
Advanced Solid TumorsOncologyLymphoma+3 more
Azienda USL Reggio Emilia - IRCCS75 enrolled1 locationNCT06795815
Recruiting
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
Chronic Lymphocytic LeukemiaRefractory LeukemiaRelapse Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto321 enrolled27 locationsNCT04282811
Recruiting
Phase 3
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto414 enrolled48 locationsNCT04168502
Recruiting
Not Applicable
Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention
Leukemia, Acute LymphoblasticMyeloid Leukemia, Acute
Azienda Ospedaliero-Universitaria di Parma100 enrolled8 locationsNCT06626893
Recruiting
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Acute Myeloid LeukemiaFamilial Acute Myeloid LeukemiaMyelodysplastic Syndromes
Gruppo Italiano Malattie EMatologiche dell'Adulto237 enrolled27 locationsNCT04460950